These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27512119)

  • 1. CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways.
    Berchiche YA; Sakmar TP
    Mol Pharmacol; 2016 Oct; 90(4):483-95. PubMed ID: 27512119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-X-C Motif Chemokine Receptor 3 Splice Variants Differentially Activate Beta-Arrestins to Regulate Downstream Signaling Pathways.
    Smith JS; Alagesan P; Desai NK; Pack TF; Wu JH; Inoue A; Freedman NJ; Rajagopal S
    Mol Pharmacol; 2017 Aug; 92(2):136-150. PubMed ID: 28559424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes.
    Korniejewska A; McKnight AJ; Johnson Z; Watson ML; Ward SG
    Immunology; 2011 Apr; 132(4):503-15. PubMed ID: 21255008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
    Lasagni L; Francalanci M; Annunziato F; Lazzeri E; Giannini S; Cosmi L; Sagrinati C; Mazzinghi B; Orlando C; Maggi E; Marra F; Romagnani S; Serio M; Romagnani P
    J Exp Med; 2003 Jun; 197(11):1537-49. PubMed ID: 12782716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Label-free impedance responses of endogenous and synthetic chemokine receptor CXCR3 agonists correlate with Gi-protein pathway activation.
    Watts AO; Scholten DJ; Heitman LH; Vischer HF; Leurs R
    Biochem Biophys Res Commun; 2012 Mar; 419(2):412-8. PubMed ID: 22349504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chemokines CXCL9, CXCL10, and CXCL11 differentially stimulate G alpha i-independent signaling and actin responses in human intestinal myofibroblasts.
    Kouroumalis A; Nibbs RJ; Aptel H; Wright KL; Kolios G; Ward SG
    J Immunol; 2005 Oct; 175(8):5403-11. PubMed ID: 16210647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function.
    Colvin RA; Campanella GS; Sun J; Luster AD
    J Biol Chem; 2004 Jul; 279(29):30219-27. PubMed ID: 15150261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of the different natural CC chemokine receptor 2b ligands on beta-arrestin recruitment, Gαi signaling, and receptor internalization.
    Berchiche YA; Gravel S; Pelletier ME; St-Onge G; Heveker N
    Mol Pharmacol; 2011 Mar; 79(3):488-98. PubMed ID: 21088225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Analysis of CXCR3 Splicing Variants and Their Ligands Using NanoBiT-Based Molecular Interaction Assays.
    Nguyen HT; Hurh S; Nguyen LP; Nguyen TU; Park HK; Seong JY; Lee CS; Ham BJ; Hwang JI
    Mol Cells; 2023 May; 46(5):281-297. PubMed ID: 36799104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
    Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
    J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional consequences of chemically-induced β-arrestin binding to chemokine receptors CXCR4 and CCR5 in the absence of ligand stimulation.
    Liebick M; Henze S; Vogt V; Oppermann M
    Cell Signal; 2017 Oct; 38():201-211. PubMed ID: 28733085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxy-Terminal Phosphoregulation of the Long Splice Isoform of Free-Fatty Acid Receptor-4 Mediates
    Senatorov IS; Cheshmehkani A; Burns RN; Singh K; Moniri NH
    Mol Pharmacol; 2020 May; 97(5):304-313. PubMed ID: 32132133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR3 ligands in disease and therapy.
    Van Raemdonck K; Van den Steen PE; Liekens S; Van Damme J; Struyf S
    Cytokine Growth Factor Rev; 2015 Jun; 26(3):311-27. PubMed ID: 25498524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biased agonists of the chemokine receptor CXCR3 differentially control chemotaxis and inflammation.
    Smith JS; Nicholson LT; Suwanpradid J; Glenn RA; Knape NM; Alagesan P; Gundry JN; Wehrman TS; Atwater AR; Gunn MD; MacLeod AS; Rajagopal S
    Sci Signal; 2018 Nov; 11(555):. PubMed ID: 30401786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3.
    Scholten DJ; Canals M; Wijtmans M; de Munnik S; Nguyen P; Verzijl D; de Esch IJ; Vischer HF; Smit MJ; Leurs R
    Br J Pharmacol; 2012 Jun; 166(3):898-911. PubMed ID: 21883151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-biased and probe-dependent modulation of chemokine receptor CXCR3 signaling by negative allosteric modulators.
    Bernat V; Brox R; Heinrich MR; Auberson YP; Tschammer N
    ChemMedChem; 2015 Mar; 10(3):566-74. PubMed ID: 25655398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of cysteine-X-cysteine motif chemokine ligands 9, 10, and 11, their receptor CXCR3, and their possible role on the recruitment of immune cells at the maternal-conceptus interface in pigs.
    Han J; Gu MJ; Yoo I; Choi Y; Jang H; Kim M; Yun CH; Ka H
    Biol Reprod; 2017 Jul; 97(1):69-80. PubMed ID: 28859287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL4L1 and CXCL4 signaling in human lymphatic and microvascular endothelial cells and activated lymphocytes: involvement of mitogen-activated protein (MAP) kinases, Src and p70S6 kinase.
    Van Raemdonck K; Gouwy M; Lepers SA; Van Damme J; Struyf S
    Angiogenesis; 2014 Jul; 17(3):631-40. PubMed ID: 24469069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of G alpha i2 activation by G alpha i3 in CXCR3-mediated signaling.
    Thompson BD; Jin Y; Wu KH; Colvin RA; Luster AD; Birnbaumer L; Wu MX
    J Biol Chem; 2007 Mar; 282(13):9547-9555. PubMed ID: 17289675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer.
    Datta D; Flaxenburg JA; Laxmanan S; Geehan C; Grimm M; Waaga-Gasser AM; Briscoe DM; Pal S
    Cancer Res; 2006 Oct; 66(19):9509-18. PubMed ID: 17018607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.